Back to School Savings: Save up to 30% on print books and eBooks. No promo code needed.
Back to School Savings: Save up to 30%
Basics of Chimeric Antigen Receptor (CAR) Immunotherapy
1st Edition - July 19, 2019
Author: Mumtaz Y. Balkhi
Paperback ISBN:9780128195734
9 7 8 - 0 - 1 2 - 8 1 9 5 7 3 - 4
eBook ISBN:9780128197479
9 7 8 - 0 - 1 2 - 8 1 9 7 4 7 - 9
Basics of Chimeric Antigen Receptor (CAR) Immunotherapy presents the latest on how T cell adoptive immunotherapy has progressed in its ultimate goal of curing metastatic malignant… Read more
Purchase Options
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code is needed.
Basics of Chimeric Antigen Receptor (CAR) Immunotherapy presents the latest on how T cell adoptive immunotherapy has progressed in its ultimate goal of curing metastatic malignant cancers. Recent clinical data obtained with checkpoint receptor blockade inhibitors and chimeric antigen receptor (CAR) therapy has been especially promising, thus generating renewed hope that we may be on the verge of finally curing cancer. Over the years, huge progress has been made in controlling several stage IV metastasized cancers through the clinical application of checkpoint receptor inhibitory drugs and CAR-Therapy that has seen unprecedented interest in the immunotherapy field.
Presents the first book to provide a basic understanding of chimeric antigen receptor (CARs) design, production and clinical application protocols
Provides unique authority as the editor has worked directly with CARs
Discusses the challenges encountered in actual clinical trials and how these challenges can be overcome
Includes a full chapter on various challenges researchers should expect to encounter in the CAR-therapy field
Academia (research and development) who work on immunotherapies, (post) graduate students in biomedical science, researchers, scientists, (post) graduate students in translational medicine
1. An introduction to CAR immunotherapy2. Components and design of Chimeric Antigen Receptors (CARs)3. scFv cloning, vectors and CAR production in laboratory for preclinical application4. Production of CAR-T cells for clinical application5. Challenges and opportunities to improve CAR-TE cell therapy
No. of pages: 92
Language: English
Published: July 19, 2019
Imprint: Academic Press
Paperback ISBN: 9780128195734
eBook ISBN: 9780128197479
MB
Mumtaz Y. Balkhi
Dr. Mumtaz Balkhi brings dual backgrounds in cancer biology and immunotherapeutics to a research program in translational research. With a Ph.D. in Human Biology, he applies molecular biology techniques and utilizes his knowledge of molecular and cellular immunology to develop new gene therapies to improve immunotherapies against cancer. He has more than 20 publications in highly reputable journals including Science and Cell Press Journals. His 2013 publication in Science Signaling Journal featured as Cover Story and his latest publication in Cell Press journal was recently highlighted in Cell Press Crosstalk. Dr. Balkhi hopes to establish a Chimeric Antigen Receptor (CAR) Immunotherapy program. He is trained in this field and had an opportunity to drive and lead projects related to CAR Immunotherapy.
Affiliations and expertise
Professor, Chief Scientific Officer, Immunotherapeutic Lab (ITL)